angiotensin ii has been researched along with Cancer of Ovary in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakar, SS; Straughn, AR | 1 |
| Ayhan, S; Beyazit, F; Celik, HT; Gungor, T | 1 |
| Greish, K; Maeda, H; Nagamitsu, A | 1 |
| Ino, K; Kajiyama, H; Kikkawa, F; Mizutani, S; Nagasaka, T; Shibata, K; Suganuma, T | 1 |
| Hino, N; Mitsuhata, N; Nishigaki, S; Suga, K; Tagusagawa, Y | 1 |
| Brown, JJ; Ferriss, JB; Fraser, R; Lever, AF; Robertson, JI | 1 |
| Hasegawa, E | 1 |
| Andoh, I; Fujimaru, J; Harada, M; Hirabayashi, K; Iguchi, T; Matsushiro, N; Satoh, M; Shima, Y; Takizawa, K; Yokoo, I | 1 |
| Akizuki, H; Higashijima, H; Kishi, N; Matsumura, T; Nishimura, H; Yakushiji, M | 1 |
| Fujimaru, J; Harada, M; Iguchi, T; Ozaki, I; Sato, M; Shima, Y; Takeda, Y; Takizawa, K; Yokoo, I | 1 |
2 review(s) available for angiotensin ii and Cancer of Ovary
| Article | Year |
|---|---|
Withaferin A: a potential therapeutic agent against COVID-19 infection.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Cachexia; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Mice; Ovarian Neoplasms; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; RNA, Messenger; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Withanolides; Xenograft Model Antitumor Assays | 2020 |
Primary hyperaldosteronism.
Topics: Adenoma; Adolescent; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; Angiotensin II; Child; Circadian Rhythm; Desoxycorticosterone; Dexamethasone; Diagnosis, Differential; Female; Fludrocortisone; Humans; Hyperaldosteronism; Male; Middle Aged; Ovarian Neoplasms; Phlebography; Potassium; Renin; Sodium; Tomography, X-Ray Computed; Ultrasonography; Urea | 1981 |
1 trial(s) available for angiotensin ii and Cancer of Ovary
| Article | Year |
|---|---|
[The clinical and pharmacokinetic evaluation of two-route chemotherapy with cisplatin and sodium thiosulfate in combination with angiotensin II].
Topics: Angiotensin II; Blood Pressure; Cisplatin; Drug Therapy, Combination; Female; Humans; Ovarian Neoplasms; Thiosulfates; Vasoconstriction | 1992 |
7 other study(ies) available for angiotensin ii and Cancer of Ovary
| Article | Year |
|---|---|
Assessment of serum angiotensin-converting enzyme in patients with epithelial ovarian cancer.
Topics: Adult; Aged; Angiotensin II; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Case-Control Studies; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Statistics, Nonparametric | 2015 |
Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors.
Topics: Adenocarcinoma; Adult; Aged; Angiotensin II; Antineoplastic Agents; Blood Pressure; Carcinoma, Renal Cell; Cholangiocarcinoma; Drug Delivery Systems; Female; Humans; Hypertension; Infusions, Intravenous; Japan; Kidney Neoplasms; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Polystyrenes; Vasoconstrictor Agents; Zinostatin | 2009 |
Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Topics: Adenocarcinoma; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antigens, CD34; Benzimidazoles; Biphenyl Compounds; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Ovarian Neoplasms; Peritoneum; Receptor, Angiotensin, Type 1; Tetrazoles; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2005 |
[Intracarotid arterial infusion with CDDP in combination with angiotensin II].
Topics: Adenocarcinoma, Papillary; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carotid Arteries; Cisplatin; Doxorubicin; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Ovarian Neoplasms | 1984 |
[Blood flow pattern and tumor vascular change following intraperitoneal administration of CDDP in VX2 ovarian tumor].
Topics: Angiotensin II; Animals; Blood Pressure; Cisplatin; Female; Hemodynamics; Infusions, Parenteral; Neoplasm Transplantation; Ovarian Neoplasms; Rabbits; Regional Blood Flow | 1993 |
[Dynamic CT under angiotensin II-induced hypertension--application for the differential diagnosis between benign and malignant solid ovarian tumors].
Topics: Adult; Angiotensin II; Blood Pressure; Diagnosis, Differential; Female; Humans; Middle Aged; Ovarian Neoplasms; Regional Blood Flow; Tomography, X-Ray Computed | 1990 |
[The hypertensive effect induced with angiotensin II and the physiological and pharmacokinetic aspects of two-route chemotherapy using CDDP and STS].
Topics: Angiotensin II; Blood Pressure; Cisplatin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Ovarian Neoplasms; Thiosulfates | 1990 |